API | diroximel

diroximel (Vumerity) Report issue

Small molecule Approved ^FDA

AACT PubChem

Active Ingredient History

NOW

Chemistry

SMILES: COC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O
InChIKey: YIMYDTCOUQIDMT-SNAWJCMRSA-N
Mol. Mass: 255.23
ALogP: -0.59 Partition coefficient
ChEMBL Molecule:
diroximel fumarate

More Chemistry

Pharmacology

Mechanisms of Action:
- Kelch-like ECH-associated protein 1 (Homo sapiens) ^UniProt
- Kelch-like ECH-associated protein 1 (Homo sapiens) ^UniProt
- Nuclear factor erythroid 2-related factor 2 (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Prescription Only
Delivery Methods: Oral
Pro Drug: Yes

Drug Pricing (per unit)

United States

$44.4455 - $54.3375

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

alks 8700

Organizations (4)

Research & Development (3)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (2)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (3)

Approved Indications (1)

Multiple Sclerosis (approved 2019)

Experimental Indications - Clinical Trial Phases 1-4 (3)

Healthy Volunteers (Phase 1)

Multiple Sclerosis (Phase 3)

Multiple Sclerosis, Relapsing-Remitting (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 5
# of Trial Organizations: 3

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue